Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition.

Saved in:
Bibliographic Details
Title: Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition.
Authors: Sheppard SE; Center for Applied Genomics.; Division of Human Genetics, and., March ME; Center for Applied Genomics., Seiler C; Zebrafish Core, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Matsuoka LS; Center for Applied Genomics., Kim SE; Center for Applied Genomics., Kao C; Center for Applied Genomics., Rubin AI; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Battig MR; Center for Applied Genomics., Khalek N; Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment and., Schindewolf E; Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment and., O'Connor N; Center for Applied Genomics., Pinto E; Jill and Mark Fishman Center for Lymphatic Disorders, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Priestley JR; Division of Human Genetics, and., Sanders VR; Division of Human Genetics, and., Niazi R; Genetic Diagnostic Laboratory, Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ganguly A; Genetic Diagnostic Laboratory, Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Hou C; Center for Applied Genomics., Slater D; Center for Applied Genomics., Frieden IJ; Department of Dermatology and., Huynh T; Department of Dermatology and., Shieh JT; Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA., Krantz ID; Division of Human Genetics, and.; Roberts Individualized Medical Genetics Center, Division of Human Genetics., Guerrero JC; Department of Pathology., Surrey LF; Department of Pathology., Biko DM; Department of Radiology., Laje P; Department of Surgery; and., Castelo-Soccio L; Dermatology Section, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Nakano TA; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA., Snyder K; Division of Oncology, Cancer Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Smith CL; Jill and Mark Fishman Center for Lymphatic Disorders, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Li D; Center for Applied Genomics., Dori Y; Jill and Mark Fishman Center for Lymphatic Disorders, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Hakonarson H; Center for Applied Genomics.
Source: JCI insight [JCI Insight] 2023 May 08; Vol. 8 (9). Date of Electronic Publication: 2023 May 08.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first